In Vivo Mapping of Notch Pathway Activity in Normal and Stress Hematopoiesis

Artavanis-Tsakonas, 1995, Notch signaling, Science, 268, 225, 10.1126/science.7716513 Butler, 2010, Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells, Cell Stem Cell, 6, 251, 10.1016/j.stem.2010.02.001 Ciofani, 2005, Notch promotes survival of pre-T cells at the β-selection checkpoint by regulating cellular metabolism, Nat. Immunol., 6, 881, 10.1038/ni1234 Clements, 2011, A somitic Wnt16/Notch pathway specifies haematopoietic stem cells, Nature, 474, 220, 10.1038/nature10107 Dzierzak, 2008, Of lineage and legacy: the development of mammalian hematopoietic stem cells, Nat. Immunol., 9, 129, 10.1038/ni1560 Eschbach, 1987, Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial, N. Engl. J. Med., 316, 73, 10.1056/NEJM198701083160203 Fiorini, 2009, Dynamic regulation of notch 1 and notch 2 surface expression during T cell development and activation revealed by novel monoclonal antibodies, J. Immunol., 183, 7212, 10.4049/jimmunol.0902432 Fre, 2011, Notch lineages and activity in intestinal stem cells determined by a new set of knock-in mice, PLoS ONE, 6, e25785, 10.1371/journal.pone.0025785 Grabher, 2006, Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia, Nat. Rev. Cancer, 6, 347, 10.1038/nrc1880 Hirata, 2002, Oscillatory expression of the bHLH factor Hes1 regulated by a negative feedback loop, Science, 298, 840, 10.1126/science.1074560 Jackson, 1973, Cholinesterase as a possible marker for early cells of the megakaryocytic series, Blood, 42, 413, 10.1182/blood.V42.3.413.413 Kleinmann, 2008, Ikaros represses the transcriptional response to Notch signaling in T-cell development, Mol. Cell. Biol., 28, 7465, 10.1128/MCB.00715-08 Klinakis, 2011, A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia, Nature, 473, 230, 10.1038/nature09999 Kopan, 2009, The canonical Notch signaling pathway: unfolding the activation mechanism, Cell, 137, 216, 10.1016/j.cell.2009.03.045 Kühn, 1995, Inducible gene targeting in mice, Science, 269, 1427, 10.1126/science.7660125 Kumano, 2003, Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells, Immunity, 18, 699, 10.1016/S1074-7613(03)00117-1 Lobry, 2011, Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think, J. Exp. Med., 208, 1931, 10.1084/jem.20111855 Lobry, 2013, Notch pathway activation targets AML-initiating cell homeostasis and differentiation, J. Exp. Med., 210, 301, 10.1084/jem.20121484 Luche, 2007, Faithful activation of an extra-bright red fluorescent protein in “knock-in” Cre-reporter mice ideally suited for lineage tracing studies, Eur. J Immunol., 43, 10.1002/eji.200636745 Maillard, 2008, Canonical notch signaling is dispensable for the maintenance of adult hematopoietic stem cells, Cell Stem Cell, 2, 356, 10.1016/j.stem.2008.02.011 Mancini, 2005, Jagged1-dependent Notch signaling is dispensable for hematopoietic stem cell self-renewal and differentiation, Blood, 105, 2340, 10.1182/blood-2004-08-3207 Melnikova, 2006, Anaemia therapies, Nat. Rev. Drug Discov., 5, 627, 10.1038/nrd2113 Mercher, 2008, Notch signaling specifies megakaryocyte development from hematopoietic stem cells, Cell Stem Cell, 3, 314, 10.1016/j.stem.2008.07.010 Moriyama, 2008, Delta-like 1 is essential for the maintenance of marginal zone B cells in normal mice but not in autoimmune mice, Int. Immunol., 20, 763, 10.1093/intimm/dxn034 Ng, 2009, Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells, Immunity, 30, 493, 10.1016/j.immuni.2009.01.014 Novershtern, 2011, Densely interconnected transcriptional circuits control cell states in human hematopoiesis, Cell, 144, 296, 10.1016/j.cell.2011.01.004 Ntziachristos, 2012, Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia, Nat. Med., 18, 298, 10.1038/nm.2651 Orkin, 2008, Hematopoiesis: an evolving paradigm for stem cell biology, Cell, 132, 631, 10.1016/j.cell.2008.01.025 Peslak, 2012, EPO-mediated expansion of late-stage erythroid progenitors in the bone marrow initiates recovery from sublethal radiation stress, Blood, 120, 2501, 10.1182/blood-2011-11-394304 Poirault-Chassac, 2010, Notch/Delta4 signaling inhibits human megakaryocytic terminal differentiation, Blood, 116, 5670, 10.1182/blood-2010-05-285957 Pronk, 2007, Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy, Cell Stem Cell, 1, 428, 10.1016/j.stem.2007.07.005 Puente, 2011, Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia, Nature, 475, 101, 10.1038/nature10113 Ruzankina, 2007, Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss, Cell Stem Cell, 1, 113, 10.1016/j.stem.2007.03.002 Seibler, 2003, Rapid generation of inducible mouse mutants, Nucleic Acids Res., 31, e12, 10.1093/nar/gng012 Sekine, 2009, Differential regulation of splenic CD8- dendritic cells and marginal zone B cells by Notch ligands, Int. Immunol., 21, 295, 10.1093/intimm/dxn148 Srinivas, 2001, Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus, BMC Dev. Biol., 1, 4, 10.1186/1471-213X-1-4 Stadtfeld, 2005, Assessing the role of hematopoietic plasticity for endothelial and hepatocyte development by non-invasive lineage tracing, Development, 132, 203, 10.1242/dev.01558 Tanigaki, 2002, Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells, Nat. Immunol., 3, 443, 10.1038/ni793 van der Putten, 2008, Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure, Nat. Clin. Pract. Nephrol., 4, 47, 10.1038/ncpneph0655 Varnum-Finney, 2011, Notch2 governs the rate of generation of mouse long- and short-term repopulating stem cells, J. Clin. Invest., 121, 1207, 10.1172/JCI43868